ARCALYST, created in 2006 (United States), from 16 sister brands and 2214 competing brands. ARCALYST is a brand of Regeneron Pharmaceuticals, listed on the stock exchange of New York. The sector of ARCALYST is Biotechnology.

ARCALYST is a brand of Regeneron Pharmaceuticals (REGN) Share price

International deposit : 2006 Business sector Biotechnology

Share price and profitability of the share Regeneron Pharmaceuticals (ARCALYST)

Buy Regeneron Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 893.99

Portfolio valuation
Regeneron Pharmaceuticals (ARCALYST) over 5 years* USD 2,353.80

Stock market history Regeneron Pharmaceuticals (ARCALYST)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Regeneron Pharmaceuticals

See more brands of Regeneron Pharmaceuticals

Rival brands
ARCALYST

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS